General characteristics of an early arthritis cohort in Argentina

Rheumatology

Volumn 50, Issue 1, 2011, Pages 110-116

  Marcos, Josefina ^a   Waimann, Christian ^b   Dal Pra, Fernando ^b   Hogrefe, Jimena ^b   Retamozo, Soledad ^c   Caeiro, Francisco ^c   Casalla, Luciana ^d   Benegas, Mariana ^d   Rillo, Oscar ^d   Spindler, Alberto ^e   Berman, Horacio ^e   Berman, Alberto ^e   Secco, Anastasia ^f   Salinas, Rodrigo García ^f   Pellet, Antonio Catalán ^f   Ceccato, Federico ^g   Paira, Sergio ^g   Marcos, Juan C ^a   Cocco, José A Maldonado ^b   Citera, Gustavo ^b  

^a HOSPITAL SAN MARTÍN   (Argentina)

^b Section of Rheumatology   (Argentina)

^c HOSPITAL PRIVADO   (Argentina)

^d Tornu Hospital   (Argentina)

^e Hospital Padilla ^*  (Argentina)

^f Hospital Bernardino Rivadavia   (Argentina)

^g Hospital Jose M Cullen   (Argentina)

Author keywords

Early arthritis; Early arthritis clinics; Medical education; Rheumatoid arthritis; Work disability

Indexed keywords

CYCLIC CITRULLINATED PEPTIDE ANTIBODY; DISEASE MODIFYING ANTIRHEUMATIC DRUG; RHEUMATOID FACTOR;

ADULT; ANKYLOSING SPONDYLITIS; ARGENTINA; ARTHRITIS; ARTICLE; CLINICAL STUDY; COHORT ANALYSIS; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; CRYSTAL ARTHROPATHY; DEMOGRAPHY; DISEASE ACTIVITY; DISEASE DURATION; ECONOMIC ASPECT; FAMILIAL DISEASE; FEMALE; FOOT RADIOGRAPHY; FUNCTIONAL STATUS; GENETIC DISORDER; HAND RADIOGRAPHY; HEALTH INSURANCE; HUMAN; JOINT SWELLING; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PSORIATIC ARTHRITIS; QUALITY OF LIFE; RHEUMATOID ARTHRITIS; RHEUMATOLOGY; SOCIAL ASPECT; UNDIFFERENTIATED ANKYLOSING SPONDYLITIS; UNDIFFERENTIATED ARTHRITIS; UNDIFFERENTITED ANKYLOSING SPONDYLITIS; UNIVERSITY HOSPITAL;

ADULT; ARGENTINA; ARTHRITIS; COHORT STUDIES; DISABILITY EVALUATION; EDUCATION, MEDICAL, CONTINUING; FEMALE; HUMANS; JOINTS; MALE; MIDDLE AGED; QUESTIONNAIRES; RHEUMATOLOGY; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 79951698249     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/keq220     Document Type: Article

References (49)

1. Kelley WN, Harris ED Jr, Ruddy S et al. Textbook of rheumatology. Philadelphia: WB Saunders, 1989.
2. McCarty DJ. Arthritis and allied conditions. A textbook of rheumatology. Philadelphia: Lea & Ferbirger, 1985.
3. Spindler A, Bellomio V, Berman A et al. Prevalence of rheumatoid arthritis in Tucumán, Argentina. J Rheumatol 2002;29:1166-70.
4. Scublinsky D, Hofman J, Somma LF et al. Prevalencia de artritis reumatoidea en la ciudad de lujan [Prevalence of rheumatoid arthritis in the city of Lujan]. Rev Arg Reumatol 2009;20(Suppl. 2):20.
5. Pincus T, Callahan LF. Taking mortality in rheumatoid arthritis seriously-predictive markers, socioeconomic status and comorbidity. J Rheumatol 1986;13:841-5.
6. Pincus T, Brooks RH, Callahan LF. Prediction of long term mortality in patients with rheumatoid arthritis according to simple questionnaire and joint count measures. Ann Intern Med 1994;120:26-34.
7. Pincus T, Callahan LF, Sale WG, Brooks AL, Payne LE, Vaughn WK. Severe functional declines, work disability, and increased mortality in seventy-five rheumatoid arthritis patients studied over nine years. Arthritis Rheum 1984;27: 864-72.
8. Dixey J, Solymossy C, Young A. Is it possible to predict radiological damage in early rheumatoid arthritis (RA)? A report on the occurrence, progression, and prognostic factors of radiological erosions over the first 3 years in 866 patients from the Early RA Study (ERAS). J Rheumatol 2004;31(Suppl. 69):48-54.
9. Young A, Dixey J, Cox N et al. How does functional disability in early rheumatoid arthritis (RA) affect patients and their lives? Results of 5 years of follow-up in 732 patients from the Early RA Study (ERAS). Ann Rheum Dis 2002;61: 335-40.
10. Hogrefe JF, Marengo MF, Schneeberger EE et al. Valores de corte de HAQ para predecir discapacidad laboral en pacientes con artritis Reumatoidea [HAQ's cut-off points to predict work disability in patients with rheumatoid arthritis]. Rev Arg Reumatol 2009;20:23-7.
11. James D, Young A, Kulinskaya E. Orthopaedic intervention in early rheumatoid arthritis. Occurrence and predictive factors in an inception cohort of 1064 patients followed for 5 years. Rheumatology 2004;43: 369-76.
12. Emery P, Salmon M. Early rheumatoid arthritis: time to aim for remission? Ann Rheum Dis 1995;54:944-7.
13. Kavanaugh A. Economic consequences of established rheumatoid arthritis and its treatment. Best Pract Res Clin Rheumatol 2007;21:929-42.
14. Klarenbeek NB, Allaarta CF, Kerstensb PJSM et al. The BeSt story: on strategy trials in rheumatoid arthritis. Curr Opin Rheumatol 2009;21:291-8.
15. Cush JJ. Early rheumatoid arthritis - is there a window of opportunity? J Rheumatol Suppl 2007;80:1-7.
16. Young A. What have we learnt from early rheumatoid arthritis cohorts? Best Pract Res Clin Rheum 2009;23: 3-12.
17. Prevoo MLL, van't Hof MA, Kuper HH et al. Modified disease activity scores that include twenty-eight joint count. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995;38:44-8.
18. Citera G, Arriola MS, Maldonado-Cocco JA. Validation and crosscultural adaptation of an Argentine Spanish version of the Health Assessment Questionnaire Disability Index. J Clin Rheumatol 2004;10:110-5.
19. Waimann CA, Dal Pra FM, Citera G et al. Validación de una versión argentina del HAQ-II [Validation of an Argentine version of the HAQ II]. Rev Arg Reumatol 2008;19:40(43).
20. Citera G, Soriano E, SantillánMet al. Adaptacion cultural y validacion de una version argentina del RADAI (Rheumatoid Arthritis Disease Activity Index) [Validation and cross-cultural adaptation of an Argentine version of the RADAI (Rheumatoid Arthritis Disease Activity Index)]. Poster. 37° Congreso Argentino de Reumatología (Buenos Aires, 2004).
21. Waimann CA, Dal Pra FM, Marengo MF et al. Validación de una versión argentina del RAQoL [Validation of an Argentine version of the RAQoL (Rheumatoid Arthritis Quality of Life)]. Rev Arg Reumatol 2008;19:20(13).
22. Finckh A, Liang MH, Van Herckenrode CM, De Pablo P. Long-term impact of early treatment on radiographic progression in rheumatoid arthritis: a metaanalysis. Arthritis Rheum 2006;55:864-72.
23. Lard LR, Visser H, Speyer I et al. Early versus delayed treatment in patients with recent-onset rheumatoid arthritis: comparison of two cohorts who received different treatment strategies. Am J Med 2001;111:446-51.
24. Boers M, Verhoeven AC, Markusse HM et al. Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis. Lancet 1997;350: 309-18.
25. Emery P, Breedveld FC, Hall S et al. Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomised, doubleblind, parallel treatment trial. Lancet 2008;372:375-82.
26. Grigor C, Capell H, Stirling A et al. Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomized controlled trial. Lancet 2004;364:263-9.
27. Van Aken J, Lard LR, le Cessie S et al. Radiological outcome after four years of early versus delayed treatment strategy in patients with recent onset rheumatoid arthritis. Ann Rheum Dis 2004;63:274-9.
28. Nell VPK, Machold KP, Eberl G et al. Benefit of early referral and very early therapy with disease-modifying anti-rheumatic drugs in patients with early rheumatoid arthritis. Rheumatology 2004;43:906-14.
29. Anderson JJ, Wells G, Arco C et al. Factors predicting response to treatment in rheumatoid arthritis: the importance of disease duration. Arthritis Rheum 2000;43:22-9.
30. Landewé RB, Boers M, Verhoeven AC et al. COBRA combination therapy in patients with early rheumatoid arthritis: long-term structural benefits of a brief intervention. Arthritis Rheum 2002;46:347-56.
31. Möttönen T, Hannonen P, Leirisalo-Repo M et al. FIN-RACo trial group. Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a randomised trial. Lancet 1999;353:1568-73.
32. Puolakka K, Kautiainen H, Möttönen T et al. Early suppression of disease activity is essential for maintenance of work capacity in patients with recent-onset rheumatoid arthritis: five-year experience from the FIN-RACo trial. Arthritis Rheum 2005;52:36-41.
33. Sokka T, Mäkinen H. Drug management of early rheumatoid arthritis - 2008. Best Pract Res Clin Rheum 2009;23: 93-102.
34. Quinn MA, Emery P. Window of opportunity in early rheumatoid arthritis: possibility of altering the disease process with early intervention. Clin Exp Rheumatol 2003; 21(Suppl. 31):S154-7.
35. van Dongen H, van Aken J, Lard LR et al. Efficacy of methotrexate treatment in patients with probable rheumatoid arthritis: a double-blind, randomized, placebo-controlled trial. Arthritis Rheum 2007;56:1424-32.
36. Sokka T, Pincus T. A historical perspective concerning population-based and clinical studies of early arthritis and early rheumatoid arthritis. Clin Exp Rheumatol 2003; 21(Suppl. 31):S5-14.
37. Klaus PM, Tanja AS, Gabriele JM et al. Very recent onset arthritis - clinical, laboratory, and radiological findings during the first year of disease. J Rheumatol 2002;29:11.
38. Freeston JE, Wakefield RJ, Conaghan PG et al. A diagnostic algorithm for persistence of very early inflammatory arthritis: the utility of power Doppler ultrasound when added to conventional assessment tools. Ann Rheum Dis. Advance access April 5, 2009; doi:10.1136/ard.2008 .106658.
39. van Aken J, van Bilsen JHM, Allaart CF et al. The Leiden Early Arthritis Clinic. Clin Exp Rheumatol 2003; 21(Suppl. 31):S100-5.
40. van Aken J, van Dongen H, Cessie S et al. Comparison of long term outcome of patients with rheumatoid arthritis presenting with undifferentiated arthritis or with rheumatoid arthritis: an observational cohort study. Ann Rheum Dis 2006;65:20-5.
41. Quinn MA, Green MJ, Helena Marzo-Ortega H et al. Prognostic factors in a large cohort of patients with early undifferentiated inflammatory arthritis after application of a structured management protocol. Arthritis Rheum 2003; 48:3039-45.
42. El-Gabalawy HS, Goldbach-Mansky R, Smith D et al. Association Of HLA alleles and clinical features in patients with synovitis of recent onset. Arthritis Rheum 1999;42: 1696-705.
43. Sokka T. Early rheumatoid arthritis in Finland. Clin Exp Rheumatol 2003;21(Suppl. 31):S133-7.
44. Zeidler H, Merkesdal S, Hülsemann JL. Early arthritis and rheumatoid arthritis in Germany. Clin Exp Rheumatol 2003;21(Suppl. 31):S106-12.
45. Visser H, le Cessie S, Vos K et al. How to diagnose rheumatoid arthritis early: a prediction model for persistent (erosive) arthritis. Arthritis Rheum 2002;46:357-65.
46. van der Helm-van Mil AHM, le Cessie S, van Dongen H et al. A prediction rule for disease outcome in patients with recent-onset undifferentiated arthritis: how to guide individual treatment decisions. Arthritis Rheum 2007;56: 433-40.
47. Saleem B, Mackie S, Quinn M et al. Does the use of tumour necrosis factor antagonist therapy in poor prognosis, undifferentiated arthritis prevent progression to rheumatoid arthritis? Ann Rheum Dis 2008;67: 1178-80.
48. van Gaalen FA, Visser H, Huizinga TWJ et al. A comparison of the diagnostic accuracy and prognostic value of the first and second anti-cyclic citrullinated peptides (CCP1 and CCP2) autoantibody tests for rheumatoid arthritis. Ann Rheum Dis 2005;64:1510-2.
49. Young A, Dixey J, Kulinskaya E et al. Which patients stop working because of rheumatoid arthritis? Results of five years' follow up in 732 patients from the early RA study (ERAS). Ann Rheum Dis 2002;61:335-40.